PATCH-TYPE ALOPECIA AREATA TREATED WITH COMBINATION THERAPY OF INTRALESIONAL CORTICOSTEROID, MINOXIDIL, AND VITAMIN D

Authors

  • Gusti Ayu Dea Dwi Apriza Dharmayani Resident in Dermatology and Venereology, Department of Dermatology and Venereology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
  • Ketut Kwartantaya Winaya Dermatologist and Venereologist, Department of Dermatology and Venereology, Faculty of Medicine, Udayana University, Udayana University Hospital, Badung, Bali, Indonesia
  • Firly Clarissa Suyanto Resident in Dermatology and Venereology, Department of Dermatology and Venereology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
  • Rose Widanti Sugiyanto Resident in Dermatology and Venereology, Department of Dermatology and Venereology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
  • Natasha Caroline Gigir Resident in Dermatology and Venereology, Department of Dermatology and Venereology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.51878/academia.v6i4.14613

Keywords:

Alopesia Areata, Patch-Type Alopecia Areata, Triamsinolon Asetonid Intralesi, Trikoskop, SALT

Abstract

ABSTRACT

Patch-type alopecia areata is a nonscarring hair loss disorder that may clinically resemble tinea capitis, making accurate diagnosis essential for appropriate management. This case report aimed to describe the diagnostic process, treatment, and short-term clinical response in an 18-year-old male with patch-type alopecia areata of the occipital region. A descriptive case report was conducted through dermatological examination, hair pull test, trichoscopy, potassium hydroxide (KOH) examination of hair roots, thyroid-stimulating hormone (TSH), free thyroxine (FT4), indirect immunofluorescence antinuclear antibody (ANA-IF), serum 25-hydroxyvitamin D [25(OH)D], and severity assessment using the Severity of Alopecia Tool (SALT) and Alopecia Areata Investigator Global Assessment (AA-IGA). Examination revealed several well-demarcated, skin-colored alopecic patches without scaling or scarring. The hair pull test was negative, trichoscopy showed exclamation mark hairs, and KOH examination was negative for fungal elements, supporting the diagnosis of patch-type alopecia areata. The patient received intralesional triamcinolone acetonide 10 mg/mL, topical minoxidil 5% spray, clobetasol propionate 0.05% cream, and oral vitamin D 2,000 IU. On day 18, no new patches were observed, with vellus and short terminal hair regrowth. The SALT score decreased from 20% to 10%, while AA-IGA remained at stage 1. The findings indicate short-term clinical improvement during multimodal therapy, although the response cannot be attributed to any single treatment component.

ABSTRAK

Alopesia areata tipe patch merupakan alopesia non-sikatrik yang dapat menyerupai tinea capitis, sehingga pemeriksaan klinis dan penunjang diperlukan untuk memastikan diagnosis pada kerontokan rambut terlokalisasi. Laporan kasus ini bertujuan menggambarkan proses diagnosis, tatalaksana, dan respons klinis jangka pendek pada pasien dengan alopesia areata tipe patch regio oksipital. Laporan kasus deskriptif dilakukan pada laki-laki berusia 18 tahun dengan keluhan kebotakan pada kulit kepala. Evaluasi meliputi pemeriksaan dermatologis, hair pull test, trikoskopi, KOH akar rambut, TSH, FT4, ANA-IF, kadar serum 25(OH)D, serta penilaian keparahan menggunakan Severity of Alopecia Tool (SALT) dan Alopecia Areata Investigator Global Assessment (AA-IGA). Pemeriksaan menunjukkan beberapa patch alopesia sewarna kulit, berbatas tegas, tanpa skuama atau jaringan parut, hair pull test negatif, exclamation mark hairs pada trikoskopi, dan KOH negatif terhadap elemen jamur, yang mendukung diagnosis alopesia areata tipe patch. Pasien mendapat kombinasi triamsinolon asetonid intralesi 10 mg/mL, minoksidil 5% spray topikal, klobetasol propionat 0,05% krim, dan vitamin D 2.000 IU per oral. Pada hari ke-18, tidak ditemukan patch baru dan tampak pertumbuhan rambut vellus serta terminal pendek. Skor SALT menurun dari 20% menjadi 10%, sedangkan AA-IGA tetap stadium 1. Perbaikan klinis menunjukkan respons jangka pendek selama terapi multimodal dan tidak dapat diatribusikan pada satu komponen terapi.

Downloads

Download data is not yet available.

References

Al?Dhubaibi, M. S., Alsenaid, A., Alhetheli, G., & Abd Elneam, A. I. (2023). Trichoscopy pattern in alopecia areata: A systematic review and meta?analysis. Skin Research and Technology, 29(6), e13378. https://doi.org/10.1111/srt.13378

Barton, V. R., Toussi, A., Awasthi, S., & Kiuru, M. (2022). Treatment of pediatric alopecia areata: a systematic review. Journal of the American Academy of Dermatology, 86(6), 1318-1334. https://doi.org/10.1016/j.jaad.2021.04.077

Dainichi, T., Iwata, M., & Kaku, Y. (2024). Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?. The Journal of dermatology, 51(2), 196-209. https://doi.org/10.1111/1346-8138.17064

Fukuyama, M., Ito, T., & Ohyama, M. (2022). Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines. The Journal of dermatology, 49(1), 19-36. https://doi.org/10.1111/1346-8138.16207

Gupta, A. K., Talukder, M., Venkataraman, M., & Bamimore, M. A. (2022). Minoxidil: a comprehensive review. Journal of Dermatological Treatment, 33(4), 1896-1906. https://doi.org/10.1080/09546634.2021.1945527

Harries, M. J., Ascott, A., Asfour, L., Farrant, P., Hale, G., Holmes, S., ... & Constantin, A. M. (2025). British Association of Dermatologists living guideline for managing people with alopecia areata 2024. British Journal of Dermatology, 192(2), 190-205. https://doi.org/10.1093/bjd/ljae385

Le, T. K., & Cohen, B. A. (2021). Tinea capitis: advances and a needed paradigm shift. Current opinion in pediatrics, 33(4), 387-391. https://doi.org/10.1097/MOP.0000000000001034

Lintzeri, D. A., Constantinou, A., Hillmann, K., Ghoreschi, K., Vogt, A., & Blume?Peytavi, U. (2022). Alopecia areata–Current understanding and management. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 20(1), 59-90. https://doi.org/10.1111/ddg.14689

Liu, M., Gao, Y., Yuan, Y., Yang, K., Shen, C., Wang, J., & Tian, J. (2023). Janus kinase inhibitors for alopecia areata: a systematic review and meta-analysis. JAMA network open, 6(6), e2320351. https://doi.org/10.1001/jamanetworkopen.2023.20351

Ohyama, M., Ito, T., Amoh, Y., Inui, S., Imanishi, H., Ueki, R., ... & Shimomura, Y. (2025). Japanese dermatological association's clinical practice guidelines for alopecia areata 2024: a complete English translated version. The Journal of Dermatology, 52(10), e876-e907. https://doi.org/10.1111/1346-8138.17859

Olayinka, J. T., & Richmond, J. M. (2021). Immunopathogenesis of alopecia areata. Current Research in Immunology, 2, 7–11. https://doi.org/10.1016/j.crimmu.2021.02.001

Rudnicka, L., Arenbergerova, M., Grimalt, R., Ioannides, D., Katoulis, A. C., Lazaridou, E., ... & Waskiel?Burnat, A. (2024). European expert consensus statement on the systemic treatment of alopecia areata. Journal of the European Academy of Dermatology and Venereology, 38(4), 687-694. https://doi.org/10.1111/jdv.19768

Sibbald, C. (2023). Alopecia areata: an updated review for 2023. Journal of cutaneous medicine and surgery, 27(3), 241-259. https://doi.org/10.1177/12034754231168839

Sinclair, R., Yang, C. C., Chung, W. H., Dhurat, R., Ganjoo, A., Khunkhet, S., ... & Zhou, C. (2026). Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia?Pacific Modified Delphi Expert Panel Recommendations. International Journal of Dermatology. https://doi.org/10.1111/ijd.70335

Sterkens, A., Lambert, J., & Bervoets, A. (2021). Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options. Clinical and experimental medicine, 21(2), 215-230. https://doi.org/10.1007/s10238-020-00673-w

Toussi, A., Barton, V. R., Le, S. T., Agbai, O. N., & Kiuru, M. (2021). Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review. Journal of the American Academy of Dermatology, 85(1), 162-175. https://doi.org/10.1016/j.jaad.2020.06.047

van Dalen, M., Muller, K. S., Kasperkovitz-Oosterloo, J. M., Okkerse, J. M., & Pasmans, S. G. (2022). Anxiety, depression, and quality of life in children and adults with alopecia areata: a systematic review and meta-analysis. Frontiers in Medicine, 9, 1054898. https://doi.org/10.3389/fmed.2022.1054898

Wang, H., Pan, L., & Wu, Y. (2022). Epidemiological trends in alopecia areata at the global, regional, and national levels. Frontiers in immunology, 13, 874677. https://doi.org/10.3389/fimmu.2022.874677

Yan, T., Wang, T., Tang, M., & Liu, N. (2024). Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis. Frontiers in pharmacology, 15, 1372810. https://doi.org/10.3389/fphar.2024.1372810

Zhou, C., Li, X., Wang, C., & Zhang, J. (2021). Alopecia areata: an update on etiopathogenesis, diagnosis, and management. Clinical reviews in allergy & immunology, 61(3), 403-423. https://doi.org/10.1007/s12016-021-08883-0

Downloads

Published

2026-09-16

How to Cite

Dharmayani, G. A. D. D. A., Winaya, K. K., Suyanto, F. C., Sugiyanto, R. W., & Gigir, N. C. (2026). PATCH-TYPE ALOPECIA AREATA TREATED WITH COMBINATION THERAPY OF INTRALESIONAL CORTICOSTEROID, MINOXIDIL, AND VITAMIN D. ACADEMIA: Jurnal Inovasi Riset Akademik, 6(4), 3678–3689. https://doi.org/10.51878/academia.v6i4.14613

Issue

Section

Articles